Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.

Source:http://linkedlifedata.com/resource/pubmed/id/20438536

Download in:

View as

General Info

PMID
20438536